Reperfusion, patency and reocclusion with anistreplase (APSAC) in acute myocardial infarction

This publication has 24 references indexed in Scilit:

• TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1988
• Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator.
  Circulation, 1988
• A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary Angioplasty
  New England Journal of Medicine, 1987
• Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial Infarction
  New England Journal of Medicine, 1987
• A perspective of coronary disease seen through the arteries of living man.
  Circulation, 1987
• The Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction
  New England Journal of Medicine, 1985
• Acute myocardial infarction treated with intracoronary streptokinase: A report of the society for cardiac angiography
  The American Journal of Cardiology, 1985
• Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina.
  Heart, 1985
• Thrombolytic therapy for acute transmural myocardial infarction: Intracoronary versus intravenous
  The American Journal of Medicine, 1984
• Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction
  New England Journal of Medicine, 1980